富乐律师事务所(Foley & Lardner LLP)担任皮肤癌治疗公司(SkinCure Oncology)的法律顾问。该公司作为全球领先的影像引导浅层放射治疗(Image-Guided SRT)综合服务模式提供商,此次由全球顶尖另类投资机构H.I.G. Capital旗下关联公司对其进行资本重组。
SkinCure肿瘤学与注重品质的皮肤科医生、莫氏手术医师及其他医师合作,将癌症中心级别的放射治疗引入皮肤科诊疗实践。 这项被称为"温和疗愈™体验"的影像引导同步放射治疗(SRT)——作为常见皮肤癌最先进的非手术疗法——已在全美约500位医师处开展,累计治疗患者逾10万人次。SkinCure肿瘤学现任管理团队将留任,并在重组后的企业中持有重要股权。
福里团队由合伙人罗杰·斯特罗德、史蒂文·格伦赖希和约翰·帕尔默领导,格雷戈里·内普尔与利·莱利两位合伙人协助工作,并得到律师助理丹尼尔·科斯坦迪、理查德·弗兰纳里和迈克尔·沃特金斯的支援。
人
相关新闻
January 29, 2026
Deals and Wins
Foley Advises Kaia Health on $285M Sale to Sword Health
Foley & Lardner LLP advised Kaia Health, a digital therapeutics company focused on musculoskeletal (MSK) and pulmonary care, on its $285 million sale to Sword Health.
January 26, 2026
Deals and Wins
Foley Advises SkyWater Technology in Agreement to be Acquired by IonQ
Foley & Lardner LLP served as legal advisor to SkyWater Technology (NASDAQ: SKYT), the largest exclusively U.S.-based, pure-play semiconductor foundry, in its definitive agreement to be acquired by IonQ Inc. (NYSE: IONQ), the world’s leading quantum platform company, in a cash-and-stock transaction valuing SkyWater at approximately $1.8 billion.
January 26, 2026
Deals and Wins
Foley Represents Blockstream in Acquisition of Elysium Lab and European Expansion
Foley & Lardner LLP represented Blockstream, the global leader in Bitcoin-powered financial infrastructure, in the acquisition of Lugano-based digital asset company Elysium Lab.